Beijing Becomes First Globally to Approve Novel Therapy, Marking Historic Milestone for China’s Biopharma Ambitions
China’s drug regulator approved a globally-trialled novel therapy ahead of US, Japanese, and European authorities — a historic first for Chinese biopharma
Read the full story on market.news
🇨🇳 China Stocks Regulatory biotech pharma china regulatory healthcare
What is your take? Drop your thoughts below. 